IS LEC
Here is a comprehensive high-yield exam reviewer based on your Immunology & Serology (MLS 412) notes:
IMMUNOLOGY & SEROLOGY — HIGH YIELD EXAM REVIEWER
PART 1: HISTORY OF IMMUNOLOGY
Key Scientists to Remember:
Scientist | Contribution |
|---|---|
Thucydides | 430 BC — noted recovered plague victims didn't get sick again |
Lady Mary Wortley Montagu | Advocated variolation in Britain (1718) |
Edward Jenner | 1798 — cowpox → smallpox immunity; coined "Vaccination" (vacca = cow) |
Louis Pasteur | Father of Immunology; discovered attenuation (fowl cholera, anthrax, rabies) |
Emil von Behring & Kitasato | Immune protection via serum (humoral); Nobel Prize 1901 |
Elie Metchnikoff | 1883 — identified phagocytes; cellular immunity |
Paul Ehrlich | Side-chain theory; coined "complement"; coined "horror autotoxicus" |
Elvin Kabat | Showed gamma globulin = immunoglobulin |
Rodney Porter & Gerald Edelman | Antibody structure; Nobel Prize 1972 |
Key Terms:
Immunis = Latin for "exempt"
Cross-reactivity = antibody for one antigen binds a similar antigen (cowpox → smallpox)
Herd immunity = sufficient proportion immune → prevents spread
Last natural smallpox case: Somalia, 1977
PART 2: ORGANS OF THE IMMUNE SYSTEM
Organ | Type | Function |
|---|---|---|
Bone Marrow | Primary | B-cell & NK cell maturation; all hematopoietic stem cells |
Thymus | Primary | T-cell maturation; flat, bilobed, in thorax below thyroid |
Spleen | Secondary | Largest secondary organ; filters blood; red pulp (destroys old RBCs), white pulp (lymphoid tissue, PALS = T cells) |
Lymph nodes | Secondary | Filters interstitial fluid; cortex (B cells), paracortex (T cells), medulla |
MALT | Secondary | GI, urogenital, respiratory tract; tonsils, Peyer's patches, appendix |
CALT | Secondary | Skin; intraepidermal T lymphocytes |
Lymph Node Layers: Cortex (B cells, macrophages, follicular dendritic cells) → Paracortex (T cells) → Medulla
PART 3: INNATE vs. ADAPTIVE IMMUNITY
Feature | Innate | Adaptive |
|---|---|---|
Specificity | Non-specific | Specific |
Memory | No | Yes |
Prior exposure needed | No | Yes |
Lines | 1st & 2nd | 3rd |
External Defense (1st line): Skin (keratin, lactic/fatty acids, pH 5.6), mucous membranes, lysozymes (attack gram+ bacteria), normal flora (competitive exclusion), cilia, HCl (stomach, pH ~1)
Internal Defense (2nd line): PRRs, PAMPs, Toll-Like Receptors (10 in humans), Acute Phase Reactants
Acute Phase Reactants (produced by hepatocytes/liver): CRP, Serum Amyloid A, Complement components, Alpha-1-antitrypsin, Haptoglobin, Fibrinogen, Ceruloplasmin
Exceptions: C1 = intestinal epithelial cells; Factor D = adipose tissue
PART 4: C-REACTIVE PROTEIN (CRP) — HIGH YIELD
Binds phosphocholine (calcium-dependent, nonspecific)
Activates classical complement pathway via C1q
Increases within 4–6 hours, peaks at 48 hours, half-life = 19 hours
Increases 100–1000 fold during infection
Most widely used indicator of acute inflammation
Cardiovascular risk threshold: >2 mg/L (male: 1.5 mg/L; female: 2.5 mg/L)
Pentamer (5 identical subunits); family = pentraxins
PART 5: INFLAMMATION
5 Cardinal Signs (Aulus Cornelius Celsus + Rudolf Virchow):
Redness (Rubor), Swelling (Tumor), Heat (Calor), Pain (Dolor), Loss of function (Functio Laesa)
Key Cells:
Diapedesis = WBC movement from blood vessel → tissue
Chemotaxis = movement toward site of infection following chemokines
Neutrophils mobilize in 30–60 min, last 24–48 hr
Macrophages peak at 16–44 hr
PART 6: PHAGOCYTOSIS
Steps: Adherence → Engulfment → Phagosome → Phagolysosome → Digestion → Exocytosis
Most active phagocytes: Neutrophils, Monocytes, Macrophages, Dendritic Cells
Oxygen-Dependent Killing:
HMP shunt → NADPH → Superoxide (O₂⁻) → H₂O₂ → Hypochlorite (OCl⁻/bleach) via Myeloperoxidase
Superoxide kills anaerobes; H₂O₂ kills most aerobes (except catalase-producers like Staph, MTB); Hypochlorite = most powerful, kills ALL
Oxygen-Independent: Defensins (destroy cell wall), Cathepsin G (destroy cell membrane)
Chronic Granulomatous Disease (CGD): X-linked recessive; absent NADPH oxidase → no respiratory burst → bacteria survives in phagolysosome → granuloma formation
PART 7: CELLS OF THE INNATE IMMUNE SYSTEM
Cell | % of WBC | Key Features |
|---|---|---|
Neutrophils | 50–70% | Most abundant; 2–5 lobed nucleus; first to arrive; primary granules (MPO, defensins, cathepsin G), secondary granules (lactoferrin, NADPH), tertiary (gelatinase) |
Eosinophils | 1–3% | Bilobed nucleus; orange granules; ↑ in allergy/parasites; Major Basic Protein |
Basophils | <1% | Smallest granulocyte; deep purple granules; IgE receptor; releases histamine/heparin |
Monocytes | 4–10% | Largest WBC (12–22 µm); horseshoe nucleus; precursor to macrophages; 70 hr in blood |
Mast cells | Tissue | Resemble basophils; 9–18 months lifespan; IgE-mediated allergic reactions |
Dendritic cells | Lymph nodes | Most effective APC; named for dendrite-like extensions |
NK cells | — | Kill virus-infected cells and tumors without prior exposure; uses perforins & granzymes; ADCC via CD16 |
Macrophage Locations (HIGH YIELD):
Location | Name |
|---|---|
Blood | Monocytes |
Lungs | Alveolar macrophages (dust cells) |
Liver | Kupffer cells |
Skin | Langerhans cells |
CNS | Microglial cells |
Bone | Osteoclasts |
Kidney | Mesangial cells |
Connective tissue | Histiocytes |
Lymph nodes | Dendritic cells |
PART 8: ADAPTIVE IMMUNITY
Key Features: Specificity, Memory, Increased response upon re-exposure
T cells (60–80% of lymphocytes):
Mature in thymus
CD4+ (Helper T) = 2/3 of peripheral T cells; recognize Class II MHC
CD8+ (Cytotoxic T) = 1/3; recognize Class I MHC
Mnemonic: CD4 × 2 = 8; CD8 × 1 = 8
T Cell Differentiation Stages:
Double Negative (DN) — no CD4/CD8
Double Positive (DP) — both CD4 and CD8
Positive Selection — must recognize MHC (intermediate binding)
Negative Selection — self-reactive clones eliminated (only 1–3% DP survive)
Single Positive — either CD4 or CD8
T Helper Cell Subtypes:
Subset | Cytokines Produced | Function |
|---|---|---|
Th1 | IFN-γ, IL-2, TNF-β | Intracellular pathogens; activates macrophages & cytotoxic T cells |
Th2 | IL-4, IL-5, IL-6, IL-9, IL-10, IL-13 | Extracellular pathogens; helps B cells make antibodies |
Th17 | IL-17, IL-22 | Inflammation; autoimmunity |
Th9 | IL-9 | Proinflammatory; mast cell growth |
Treg | — | CD4+CD25+; suppresses autoimmune response; 5% of CD4+ T cells |
B Cell Development:
Pro-B → Pre-B (μ chains in cytoplasm) → Immature B (complete IgM on surface) → Mature B (IgM + IgD)
Plasma cells produce antibodies; Memory cells remember antigen
Antigen-independent maturation = bone marrow
Antigen-dependent maturation = spleen/lymph nodes
Clusters of Differentiation (CD):
B cells: CD19 + surface antibody
All T cells: CD3, CD2
Helper T: CD4
Cytotoxic T: CD8
NK cells: CD16, CD56
PART 9: ANTIGENS
Immunogen = induces immune response (all immunogens are antigens; not all antigens are immunogens)
Hapten = small, antigenic but NOT immunogenic alone; needs carrier molecule; <10,000 daltons
Epitope/Determinant = molecular shape recognized by B/T cells (found on antigen)
Paratope = binding site on antibody
Factors Affecting Immunogenicity:
Foreignness, Degradability, Molecular Weight (>10,000 Da recognized; >100,000 Da most potent), Structural Stability, Chemical Complexity
Host factors: Age, Genetic predisposition (MHC genes), Overall health
Exposure: Dose, Route of inoculation
Adjuvants = substances that enhance immune response (e.g., alum, water, squalene, Complete Freund's Adjuvant)
PART 10: ANTIBODIES (IMMUNOGLOBULINS)
Structure: 2 heavy + 2 light chains (Y-shape); Fab (antigen-binding) + Fc (complement/effector binding)
Hinge region = disulfide bonds
Fab = 1 light chain + ½ heavy chain
Fc = 2 heavy chains
Heavy chain chromosomes: 14 | Kappa (κ): chromosome 2 | Lambda (λ): chromosome 22
Kappa:Lambda ratio = 3:1
Immunoglobulin Classes (HIGH YIELD):
Ig | Structure | Special Features |
|---|---|---|
IgG | Monomer | Most abundant; crosses placenta (except IgG2); longest half-life (23 days); secondary response; best at neutralization, opsonization, ADCC, precipitation; IgG3 best complement fixer |
IgM | Pentamer (10 binding sites) | First antibody produced (primary response); best at agglutination & complement fixation; J-chains; "Mabilis"; indicates acute infection |
IgA | Monomer (IgA1) + Dimer (IgA2) | IgA2 in mucosal secretions; secretory component protects from proteolytic enzymes; in breast milk |
IgE | Monomer | Allergic responses & parasites; binds mast cells/basophils via Fc-εRI; most heat-labile (56°C/30 min); lowest serum concentration (0.0005%) |
IgD | Monomer | B cell receptor; identifies mature B cells (IgM + IgD = mature) |
Bence-Jones Proteins = free light chains in urine; Multiple Myeloma; κ (60%) & λ (40%); precipitate at 60–70°C, dissolve at 100°C
Antigen-Antibody Reactions:
Affinity = single Fab–single epitope attraction
Avidity = overall strength of multivalent binding
Agglutination = IgM best (large, multivalent, bridges zeta potential of RBCs)
Precipitation = IgG best (small soluble particles)
Opsonization = enhanced phagocytosis; C3b and IgG coat pathogen
ADCC = NK cells lyse antibody-coated cells via CD16
Monoclonal Antibodies:
Hybridoma = B cell (plasma cell) fused with myeloma cell
PEG (Polyethylene Glycol) = promotes fusion
HAT medium selects hybridomas (blocks myeloma without HGPRT)
Drugs with -mab suffix = monoclonal antibodies
PART 11: COMPLEMENT SYSTEM
General: Heat-labile; major fraction of beta globulins; innate humoral immunity; produced by liver (except C1 = intestinal epithelial; Factor D = adipose)
Nomenclature:
"b" fragment = larger (binds); "a" fragment = smaller (anaphylatoxin)
Exception: C2 — "a" is LARGER, "b" is smaller
Most potent anaphylatoxin = C5a
Three Pathways:
Feature | Classical | Alternative | MBL |
|---|---|---|---|
Trigger | Ag-Ab complex (IgG or IgM) | Spontaneous C3 hydrolysis; LPS, fungal walls, viruses | Mannose on microorganism surface |
C3 Convertase | C4b2a | C3bBb (stabilized by Properdin + Mg²⁺) | C4b2a |
C5 Convertase | C4b2a3b | C3bBb3b | C4b2a3b |
Bypasses | Nothing | C1, C2, C4 | Nothing |
MAC (Membrane Attack Complex): C5b + C6 + C7 + C8 + C9 → pore formation → cell lysis
C8 starts pore formation
C9 polymerizes to initiate lysis
C3 is present in ALL pathways
Complement Regulatory Proteins:
Protein | Function |
|---|---|
DAF (CD55) | Dissociates C3 convertase; protects host cells |
MIRL (CD59) | Prevents C9 insertion → no MAC → no lysis |
C1 INH | Dissociates C1r and C1s from C1q |
Factor I | Cleaves C4b and C3b (needs Factor H as cofactor) |
Factor H | Binds C3b; prevents Alternative Pathway activation |
C4BP | Cofactor of Factor I; destroys C4b |
Disease Associations:
C1 deficiency → SLE-like syndrome
C2 deficiency → SLE-like + recurrent infection (affects classical & MBL)
C3 deficiency → severe recurrent infections (ALL pathways affected)
C5-C8 deficiency → Neisseria infections
C1 INH deficiency → Hereditary Angioedema (↑ bradykinin → ↑ vascular permeability)
Factor H deficiency → recurrent bacterial infection
Destruction In Vitro: EDTA (chelates Ca²⁺/Mg²⁺); Heat at 56°C/30 min inactivates C1, C2, C4; Storage affects C4
PART 12: HLA / MHC
Coded on short arm of chromosome 6 (6p21)
Named by Jean Dausset
Class | Molecules | Found On | Interacts With |
|---|---|---|---|
Class I | HLA-A, B, C | ALL nucleated cells | CD8+ cytotoxic T cells |
Class II | HLA-DP, DQ, DR | APCs (macrophages, B cells, dendritic cells) | CD4+ helper T cells |
Class III | — | — | Codes for TNF, C2, C4, Factor B |
HLA-DR = highest expression of Class II
HLA-C = lowest Class I expression
MHC Class I holds 8–11 amino acids; Class II holds 13–18 amino acids
HLA-G = expressed on fetal cells; prevents NK cell attack on fetus (inhibits maternal NK cells)
PART 13: CYTOKINES
Actions: Autocrine (self), Paracrine (nearby cells), Endocrine (distant sites via blood)
Five Attributes: Pleiotropy, Redundancy, Synergy, Antagonism, Cascade Induction
Key Cytokines:
Cytokine | Source | Function |
|---|---|---|
IL-1α | Macrophages, keratinocytes | Local inflammation |
IL-1β | Macrophages | Endogenous pyrogen (fever via hypothalamus) |
IL-1RA | — | Natural inhibitor of IL-1 |
TNF-α | Macrophages | Vasodilation; ↑ vascular permeability; present in RA; bone destruction via osteoclasts |
IL-6 | T/B cells, macrophages | Pleiotropic; stimulates APRs (CRP, fibrinogen, C3); activates JAK/STAT pathway |
IL-4 | Th2 | B cell activation; class switching to IgE |
IL-12 | Macrophages/DCs | Drives Th1 differentiation |
IFN-γ | Th1 | Activates macrophages; ↑ MHC expression; antagonizes IL-4 |
TGF-β | Th2/Treg | Anti-inflammatory; drives Treg formation (Foxp3); oral tolerance |
IL-10 | Tregs | Anti-inflammatory; inhibits antigen presentation |
IL-17 | Th17 | Neutrophil recruitment; antifungal/antibacterial at mucosa |
Cytokine Storm = hypercytokinemia; caused Spanish flu deaths; COVID-19, Ebola, Toxic Shock Syndrome Toxic Shock Syndrome: S. aureus TSST-1 (superantigen) → massive T cell activation → cytokine storm → shock
PART 14: HYPERSENSITIVITY
Gell-Coombs Classification:
Type | Name | Mediator | Time | Examples |
|---|---|---|---|---|
Type I | Anaphylactic/Immediate | IgE, mast cells, basophils, histamine | Minutes–hours | Anaphylaxis, allergic rhinitis, asthma, urticaria |
Type II | Antibody-mediated Cytotoxic | IgG, IgM + complement/ADCC | Hours | Blood transfusion reactions, HDN, Grave's, Myasthenia Gravis, AIHA |
Type III | Immune Complex-mediated | IgG/IgM complexes + complement | Hours–days | SLE, RA (serum sickness), Post-strep GN, Arthus reaction |
Type IV | Delayed/Cell-mediated | T cells (Th1), macrophages | 48–72 hours | Contact dermatitis (urushiol), TB skin test, Hypersensitivity pneumonitis |
Type I — Key Points:
IgE bound to mast cells/basophils via Fc-εRI receptors
Sensitization phase = first exposure → IgE production
Activation phase = re-exposure → degranulation → histamine release
Prausnitz-Küstner experiment = demonstrated passive transfer of allergy via serum
Test: Skin Prick Test (screening) → Intradermal (confirmatory); RIST = total IgE; RAST = allergen-specific IgE
Type II — Key Diseases:
Hemolytic Disease of the Newborn (HDN): Rh- mother + Rh+ baby → anti-Rh IgG crosses placenta → destroys fetal RBCs; Kernicterus = bilirubin crosses blood-brain barrier; prevent with RhoGAM
Myasthenia Gravis: Anti-ACh receptor antibodies → muscle weakness (inhibition)
Grave's Disease: TSI/TRAb binds TSH receptor → hyperthyroidism (stimulation)
Type III — Key Diseases:
SLE: ANA, anti-dsDNA, anti-Sm antibodies; immune complexes deposited in kidneys, skin, joints; butterfly rash; photosensitive; diagnosis: ANA test, ↓ complement (C3, C4)
RA: RF (IgM vs. IgG Fc) + anti-CCP; anti-CCP more specific; HLA-DR4; smoking = strongest trigger; pannus formation
Arthus Reaction: Local immune complex deposition at injection site
Type IV — Key Points:
First described by Robert Koch (1890)
Triggered by intracellular organisms: MTB, Leishmania, HSV; contact Ag: urushiol (poison ivy)
Sensitization: APCs → Th1 → memory T cells (1–2 weeks)
Re-exposure: IFN-γ, TNF → macrophage recruitment → tissue damage
PART 15: AUTOIMMUNITY
Definition: Immune system attacks self-antigens; Paul Ehrlich = "horror autotoxicus"
Tolerance Mechanisms:
Central Tolerance: Negative/positive selection in thymus (T cells) and bone marrow (B cells) during fetal development
Peripheral Tolerance: Backup; clonal deletion, anergy, Treg suppression
HLA Associations:
HLA-B27 → Ankylosing Spondylitis
HLA-DR3/DR4 → Type 1 Diabetes Mellitus, SLE
HLA-DR4 → Rheumatoid Arthritis
HLA-DR3/DQ → Sjögren's Syndrome
HLA-DR2/DR3 + C4/C2 deficiency → SLE
Systemic Autoimmune Diseases:
Disease | Key Autoantibodies | Notes |
|---|---|---|
SLE | ANA, anti-dsDNA, anti-Sm | Butterfly rash; photosensitive; multi-organ; ↓ C3/C4 during flares |
RA | RF (IgM vs IgG-Fc), anti-CCP | Anti-CCP more specific; pannus; HLA-DR4; TNF-α → osteoclasts |
Sjögren's | Anti-SSA/Ro, anti-SSB/La | Dry eyes & mouth; lymphocytic infiltration of glands |
Wegener's (GPA) | c-ANCA/PR3-ANCA (80–90%) | Vasculitis; granulomas; sinuses/lungs/kidneys |
Organ-Specific Diseases:
Disease | Organ | Autoantibody | Result |
|---|---|---|---|
Type 1 DM | Pancreas (β-cells) | Anti-GAD65, ICA, IAA, anti-IA2, anti-ZnT8 | Insulin deficiency |
Grave's | Thyroid | TRAb/TSI | Hyperthyroidism; exophthalmos |
Hashimoto's | Thyroid | Anti-TPO, anti-thyroglobulin | Hypothyroidism; weight gain |
Addison's | Adrenal cortex | 21-hydroxylase antibodies | ↓ cortisol/aldosterone; hyperpigmentation |
Pernicious Anemia | Stomach (parietal cells) | Anti-intrinsic factor | ↓ B12 → megaloblastic anemia |
Myasthenia Gravis | Neuromuscular junction | Anti-ACh receptor | Muscle weakness |
PART 16: IMMUNODEFICIENCY DISORDERS
Primary (inherited) vs. Secondary (acquired)
B-Cell Deficiencies:
Disorder | Defect | Key Feature |
|---|---|---|
Transient Hypogammaglobulinemia | Delayed T helper maturation | Resolves by 9–15 months; ↓ IgG1 |
Bruton's X-linked Agammaglobulinemia | BTK gene mutation on X chromosome | Males only; pre-B cells present but no mature B cells; absent tonsils/germinal centers; encapsulated organism infections |
Common Variable Immunodeficiency (CVID) | B cells fail to differentiate into plasma cells | Most common severe PID; ↓ IgG, IgA, IgM; normal B cell numbers |
X-linked Hyper-IgM Syndrome | CD40L (CD40 Ligand) gene mutation | No class switching; very high IgM, absent IgG/IgA/IgE |
Hyper-IgE Syndrome (Job Syndrome) | STAT3 gene mutation | Triad: Pneumonia, cutaneous abscesses, pulmonary abscesses; IgE >2000 IU/mL; neutrophils don't function at infection site |
Selective IgA Deficiency | Most common primary immunodeficiency | Impaired IgA plasma cell differentiation |
QUICK REVIEW: BOARD EXAM FAVORITES
Most potent anaphylatoxin = C5a
C8 starts pore formation in MAC; C9 initiates lysis
C3 is present in ALL complement pathways
IgM = best at agglutination & complement fixation; first antibody in primary response
IgG = most abundant; crosses placenta (not IgG2); longest half-life; best in secondary response
IgE = allergies; binds mast cells; heat-labile at 56°C
IgA = mucosal secretions; secretory component
IgD = B cell maturation marker
CD4 × MHC II = 8; CD8 × MHC I = 8
MHC coded on chromosome 6p21
Bruton's = BTK mutation; males only; pre-B cell arrest
Chronic Granulomatous Disease = no NADPH oxidase; no respiratory burst
Papain digestion = 2 Fab + 1 Fc (Pa-pa-in = 2+1=3)
HAT medium selects hybridomas; HGPRT needed to survive
Bence-Jones proteins = free light chains; precipitate at 60–70°C; dissolve at 100°C
CRP half-life = 19 hours; peaks at 48 hours; family = pentraxins
NK cells kill via "missing self" — target cells that lack Class I MHC
Germinal center = where B cell differentiation occurs (in lymph nodes)
HLA-G = protects fetus from NK cell attack
Good luck on your exams! Let me know if you want me to dive deeper into any specific topic.